Dihydroartemisinin: A new story of an old drug against Schistosoma mansoni infection

Parasitology Research

Volumn 113, Issue 1, 2014, Pages 239-241

  Li, Hong Jun ^a   Xu, Fu Liang ^a   Wang, Yun Hai ^a   Yi, Zheng Jun ^a,b   Wang, Wei ^c,d  

^a AFFILIATED HOSPITAL OF WEIFANG MEDICAL UNIVERSITY   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

^c JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

^d Key Laboratory on Technology for Parasitic Diseases Prevention and Control   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROARTEMISININ;

ARTICLE; HUMAN; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

MUS; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI;

ANIMALS; ARTEMISININS; FEMALE; MICE; PRAZIQUANTEL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SCHISTOSOMICIDES;

EID: 84891869673     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-013-3649-z     Document Type: Article

References (40)

1. Bonesso-Sabadini PI, de Souza Dias LC (2002) Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel. Mem Inst Oswaldo Cruz 97:381-385
2. Botros S, Sayed H, Amer N, El-Ghannam M, Bennett JL, Day TA (2005) Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. Int J Parasitol 35:787-791
3. Botros SS, Bennett JL (2007) Praziquantel resistance. Expert Opin Drug Discov 2:S35-S40
4. Cioli D, Botros SS, Wheatcroft-Francklow K, Mbaye A, Southgate V, Tchuenté LA, Pica-Mattoccia L, Troiani AR, El-Din SH, Sabra AN, Albin J, Engels D, Doenhoff MJ (2004) Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates. Int J Parasitol 34:979-987
5. Cioli D, Valle C, Angelucci F, Miele AE (2008) Will new antischistosomal drugs finally emerge? Trends Parasitol 24:379-382
6. Danso-Appiah A, De Vlas SJ (2002) Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends Parasitol 18:125-129
7. Danso-Appiah A, Olliaro PL, Donegan S, Sinclair D, Utzinger J (2013) Drugs for treating Schistosoma mansoni infection. Cochrane Database Syst Rev 2, CD000528
8. Doenhoff MJ, Cioli D, Utzinger J (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21:659-667
9. Fallon PG, Doenhoff MJ (1994) Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51:83-88
10. Fallon PG, Sturrock RF, Niang AC, Doenhoff MJ (1995) Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 53:61-62
11. Fenwick A, Webster JP (2006) Schistosomiasis: challenges for control, treatment and drug resistance. Curr Opin Infect Dis 19:577-582
12. Galal AM, Gul W, Slade D, Ross SA, Feng S, Hollingshead MG, Alley MC, Kaur G, ElSohly MA (2009) Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity. Bioorg Med Chem 17:741-751
13. Geary TG (2012) Are new anthelmintics needed to eliminate human helminthiases? Curr Opin Infect Dis 25:709-717
14. Gryseels B, Polman K, Clerinx J, Kestens L (2006) Human schistosomiasis. Lancet 368:1106-1118
15. Hua HY, Liang YS, Zhang Y, Wei JF, Guo HX (2010) The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China. Parasitol Res 107:873-878
16. Jordan P, Webbe G, Sturrock RF (1993) Human schistosomiasis. CAB International, Wallingford
17. Li GQ, Guo XB, Fu LC, Jian HX, Wang XH (1994) Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hyg 88:S5-S6
18. Li HJ, Wang W, Tao YH, Qu GL, Xing YT, Li YZ, Wei JY, Dai JR, Liang YS (2011a) Dihydroartemisinin-praziquantel combinations and multiple doses of dihydroartemisinin in the treatment of Schistosoma japonicum in experimentally infected mice. Ann Trop Med Parasitol 105:329-333
19. Li HJ, Wang W, Li YZ, Qu GL, Xing YT, Tao YH, Wei JY, Dai JR, Liang YS (2011b) Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum. Parasitol Res 109:515-519
20. Li HJ, Wang W, Qu GL, Tao YH, Xing YT, Li YZ, Wei JY, Dai JR, Liang YS (2011c) In-vivo activity of dihydroartemisinin against Schistosoma japonicum. Ann Trop Med Parasitol 105:181-185
21. Li HJ, Wang W, Qu GL, Li YZ, Tao YH, Xing YT, Wang XT, Dai Y, Wei JY, Dai JR, Coles GC, Liang YS (2012) Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice. Parasitol Res 110:1727-1732
22. Li HJ, Wang W, Li YZ, Qu GL, Xing YT, Qian K, Jia Y, Yang ZK, Qian YL, Dai JR, Liang YS (2013) In vivo activity of dihydroartemisinin against Schistosoma mansoni schistosomula in mice. Southeast Asian J Trop Med Public Health 44:379-387
23. Liang YS, Coles GC, Dai JR, Zhu YC, Doenhoff MJ (2001a) Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni. Ann Trop Med Parasitol 95:715-723
24. Liang YS, Coles GC, Doenhoff MJ, Southgate VR (2001b) In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel. Int J Parasitol 31:1227-1235
25. Liang YS, Dai JR, Zhu YC, Coles GC, Doenhoff MJ (2003) Genetic analysis of praziquantel resistance in Schistosoma mansoni. Southeast Asian J Trop Med Public Health 34:274-280
26. Liu R, Dong HF, Jiang MS (2012) The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China? Parasitol Res 110:1563-1564
27. Ma Y, Lu DM, Lu XJ, Liao L, Hu XS (2004) Activity of dihydroartemisinin against Leishmania donovani both in vitro and vivo. Chin Med J (Engl) 117:1271-1273
28. Melman SD, Steinauer ML, Cunningham C, Kubatko LS, Mwangi IN, Wynn NB, Mutuku MW, Karanja DM, Colley DG, Black CL, Secor WE, Mkoji GM, Loker ES (2009) Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 3:e504
29. Ni X, Chen Y (2001) In vitro study of the anti-pneumocystis carinii effect of arteminsin derivatives. Chin J Tuberc Respir Dis 24:164-167
30. Ribeiro-dos-Santos G, Verjovski-Almeida S, Leite LC (2006) Schistosomiasis - a century searching for chemotherapeutic drugs. Parasitol Res 99:505-521
31. Sarciron ME, Saccharin C, Petavy AF, Peyron F (2000) Effects of artesunate, dihydroartemisinin, and an artesunate-dihydroartemisinin combination against Toxoplasma gondii. Am J Trop Med Hyg 62:73-76
32. Shadan S (2008) Drug discovery: schistosome treatment. Nature 452:296
33. Spicher M, Roethlisberger C, Lany C, Stadelmann B, Keiser J, Ortega-Mora LM, Gottstein B, Hemphill A (2008) In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives. Antimicrob Agents Chemother 52:3447-3450
34. Tang ZH, Zhou XO, Gao XZ (2007) Effect of dihydroartemisinin on the ultrastructure of Trichomonas vaginalis trophozoites in vitro. Chin J Parasitol Parasit Dis 25:41-44
35. Tian XF, Lu SQ, Liu YM, Wang FY, Huang S (2005) Effect of dihydroartemisinin on ultrastructure of Giardia lamblia in vitro. Chin J Parasitol Parasitic Dis 23:292-295
36. Tian XF, Shen HE, Li J, Chen Y, Yang ZH, Lu SQ (2010) The effects of dihydroartemisinin on Giardia lamblia morphology and cell cycle in vitro. Parasitol Res 107:369-375
37. Tu YY (2011) The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 17:1217-1220
38. Wang W, Wang L, Liang YS (2012) Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res 111:1871-1877
39. William S, Sabra A, Ramzy F, Mousa M, Demerdash Z, Bennett JL, Day TA, Botros S (2001) Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. Int J Parasitol 31:1093-1100
40. Wu W, Wang W, Huang YX (2011) New insight into praziquantel against various developmental stages of schistosomes. Parasitol Res 109:1501-1507